Bank of America downgraded Sun Pharma stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower speciality execution. The brokerage cut its target price, flagging concerns over Ilumya’s Medicare exposure, pricing pressures, and limited earnings visibility despite strong initial performance.
Hindustan Copper shares gain 3% as company plans Rs 7,000 crore capital investment in next 5 years
Hindustan Copper shares rose after the company announced a Rs 7,000 crore investment over the next 5-6 years and signed MoUs with major PSUs to